Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease
AstraZeneca
AstraZeneca
Children's Hospital of Philadelphia
Sykehuset Telemark
Murdoch Childrens Research Institute
National Institutes of Health Clinical Center (CC)
McGill University Health Centre/Research Institute of the McGill University Health Centre
Sorlandet Hospital HF
Johns Hopkins University
Nantes University Hospital